Latest On Chembio Diagnostics, Inc (CEMI):
About Chembio Diagnostics, Inc (CEMI):
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, Hepatitis C, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, Rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.
General
- Name Chembio Diagnostics, Inc
- Symbol CEMI
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 355
- Last Split Factor1:8
- Last Split Date2012-05-30
- Fiscal Year EndDecember
- IPO Date2000-10-18
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://chembio.com
Valuation
- Forward PE 6.72
- Price/Sales (Trailing 12 Mt.) 2.77
- Price/Book (Most Recent Quarter) 3.21
- Enterprise Value Revenue 3.01
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.15
- Next Year EPS Estimate -$0.94
- Next Quarter EPS Estimate -$0.24
- Profit Margin -79%
- Operating Margin -68%
- Return on Assets -23%
- Return on Equity -99%
- Revenue 32.47 million
- Earnings Per Share -$0.73
- Revenue Per Share $1.7
- Gross Profit -912784
- Quarterly Earnings Growth 49.3%
Highlights
- Market Capitalization 84.97 million
- EBITDA -10184776
- PEG Ratio -0.48
- Analyst Target Price $9
- Book Value Per Share $1.38
Share Statistics
- Shares Outstanding 20.18 million
- Shares Float 18.41 million
- % Held by Insiders 1389%
- % Held by Institutions 33.75%
- Shares Short 2.19 million
- Shares Short Prior Month 3.16 million
- Short Ratio 2.38
- Short % of Float 11%
- Short % of Shares Outstanding 11%
Technicals
- Beta 1.96
- 52 Week High $15.89
- 52 Week Low $3.01
- 50 Day Moving Average 5.99
- 200 Day Moving Average 5.3
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Chembio Diagnostics, Inc (CEMI) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Chembio Diagnostics, Inc (CEMI) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-03-12 | $10.23 million | -$0.35 | -$0.28 | -25% |
2020-09-30 | 2020-11-05 | $10.27 million | -$0.28 | -$0.26 | -7.69% |
2020-06-30 | 2020-08-06 | $N/A | -$0.42 | -$0.40 | -6.33% |
2020-03-31 | 2020-05-04 | $N/A | -$0.29 | -$0.23 | -27.47% |
2019-12-31 | 2020-03-12 | $6.85 million | -$0.23 | -$0.25 | 6.12% |
2019-09-30 | 2019-11-07 | $9.72 million | -$0.22 | -$0.17 | -29.41% |
2019-06-30 | 2019-08-06 | $9.59 million | -$0.19 | -$0.15 | -24.59% |
2019-03-31 | 2019-05-01 | $8.3 million | -$0.16 | -$0.15 | -6.67% |
2018-12-31 | 2019-03-07 | $7.6 million | -$0.21 | -$0.17 | -25.37% |
2018-09-30 | 2018-11-08 | $9.38 million | -$0.16 | -$0.12 | -33.33% |
2018-06-30 | 2018-08-08 | $8.72 million | -$0.12 | -$0.07 | -71.43% |
2018-03-31 | 2018-05-09 | $7.72 million | -$0.05 | -$0.14 | 64.29% |
2017-12-31 | 2018-03-08 | $5.99 million | -$0.16 | -$0.11 | -49.95% |
2017-09-30 | 2017-11-08 | $7.59 million | -$0.05 | -$0.11 | 54.55% |
2017-06-30 | 2017-08-09 | $4.12 million | -$0.18 | -$0.17 | -9.09% |
2017-03-31 | 2017-05-09 | $6.33 million | -$0.13 | -$0.20 | 33.33% |
2016-12-31 | 2017-03-07 | $4.26 million | -$0.21 | -$0.17 | -25.97% |
2016-09-30 | 2016-11-10 | $3.75 million | -$0.19 | -$0.17 | -9.64% |
2016-06-30 | 2016-08-11 | $3.27 million | -$0.86 | -$0.17 | -405.88% |
2016-03-31 | 2016-05-12 | $6.6 million | -$0.03 | -$0.09 | 66.67% |
2015-12-31 | 2016-03-08 | $4.42 million | -$0.07 | -$0.07 | 4.5% |
2015-09-30 | 2015-11-12 | $6.89 million | -$0.05 | -$0.07 | 28.57% |
2015-06-30 | 2015-08-06 | $6.72 million | -$0.07 | ||
2015-03-31 | 2015-05-07 | $6.23 million | -$0.07 | -$0.11 | 36.36% |
2014-12-31 | 2015-03-05 | $7.1 million | -$0.05 | -$0.03 | -66.67% |
2014-09-30 | 2014-11-06 | $7.31 million | -$0.03 | -$0.02 | -50% |
2014-06-30 | 2014-08-07 | $7.42 million | -$0.02 | -$0.02 | 0% |
2014-03-31 | 2014-05-08 | $5.81 million | -$0.02 | -$0.01 | -100% |
2013-12-31 | 2014-03-06 | $7.86 million | -$0.03 | $0.04 | -175% |
2013-09-30 | 2013-11-07 | $9.62 million | $0.07 | $0.08 | -12.5% |
2013-06-30 | 2013-08-08 | $5.39 million | -$0.03 | -$0.04 | 25% |
2013-03-31 | 2013-05-09 | $6.68 million | $0.04 | $0.02 | 100% |
2012-12-31 | 2013-03-07 | $7.87 million | $0.06 | $0.05 | 20% |
2012-09-30 | 2012-11-13 | $5.01 million | -$0.04 | $0.04 | -200% |
2012-06-30 | 2012-08-09 | $6.08 million | $0.04 | $0.03 | 33.33% |
2012-03-31 | 2012-05-08 | $6.65 million | $0.08 | ||
2011-12-31 | 2012-03-08 | $6.22 million | $0.66 | ||
2011-09-30 | 2011-11-03 | $5.92 million | $0.06 | ||
2011-06-30 | 2011-08-04 | $3.61 billion | $0.02 | ||
2011-03-31 | 2011-05-05 | $3.64 million | -$0.02 | ||
2010-12-31 | 2011-03-03 | $5.67 million | $0.24 | ||
2010-09-30 | 2010-11-04 | $4.51 million | $0.02 | ||
2010-06-30 | 2010-07-29 | $3.75 million | $0.08 | -$0.08 | 200% |
2010-03-31 | 2010-05-06 | $2.78 million | -$0.02 | ||
2009-12-31 | 2010-03-05 | $3.55 million | $0.03 | ||
2009-09-30 | 2009-11-05 | $4.36 million | $0.03 | ||
2009-06-30 | 2009-08-07 | $3.37 million | $0.01 | ||
2009-03-31 | 2009-05-08 | $2.55 million | -$0.04 | ||
2008-09-30 | 2008-11-12 | $3.52 million | -$0.03 | -$0.08 | 61.75% |
2008-06-30 | 2008-08-04 | $2.72 million | -$0.08 | -$0.08 | 0% |
2008-03-31 | 2008-05-12 | $2.37 million | -$0.08 | -$0.16 | 50% |
2007-12-31 | 2008-03-12 | $2.38 million | -$2.56 | -$0.80 | -220% |
2007-09-30 | 2007-11-01 | $2.31 million | -$0.56 | -$0.96 | 41.67% |
2007-06-30 | 2007-08-09 | $2.5 million | -$0.65 | ||
2007-03-31 | 2007-05-11 | $2.04 million | -$0.72 | -$1.04 | 30.77% |
2006-12-31 | 2007-03-29 | $2.61 million | -$1.84 | -$0.96 | -91.67% |
2006-09-30 | 2006-11-14 | $1.02 million | -$1.70 | ||
2006-06-30 | 2006-08-14 | $1.64 million | -$1.07 | ||
2006-03-31 | 2006-05-15 | $1.24 million | -$1.72 | ||
2005-09-30 | 2005-11-14 | $944000 | -$1.02 | ||
2005-06-30 | 2005-08-14 | $906000 | -$1.17 | ||
2005-03-31 | 2005-05-15 | $732000 | -$4.03 | ||
2004-12-31 | 2005-03-23 | $1.16 million | -$3.52 | ||
2004-09-30 | 2004-11-15 | $566000 | -$1.43 | ||
2004-06-30 | 2004-08-17 | $996000 | -$1.05 | ||
2004-03-31 | 2004-05-13 | $585000 | -$0.72 | ||
2003-09-30 | 2003-11-15 | $N/A | $0.01 | ||
2003-06-30 | 2003-08-17 | $N/A | -$0.01 | ||
2003-03-31 | 2003-03-31 | $N/A | $0.05 | ||
2002-12-31 | 2002-12-31 | $N/A | -$0.04 | ||
2001-06-30 | 2001-06-30 | $8000 | $0.12 |
Chembio Diagnostics, Inc (CEMI) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Chembio Diagnostics, Inc (CEMI) Chart:
Chembio Diagnostics, Inc (CEMI) News:
Below you will find a list of latest news for Chembio Diagnostics, Inc (CEMI) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Chembio Diagnostics, Inc (CEMI) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest CEMI Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:23 PM EST | 100 | $0.6936 |
Jun 13, 2022 7:29 PM EST | 100 | $0.6757 |
Jun 13, 2022 7:42 PM EST | 100 | $0.6794 |
Chembio Diagnostics, Inc (CEMI) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120014016/0001140361-20-014016-index.htm |
2018-09-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1092662/000000000018029960/0000000000-18-029960-index.htm |
2020-06-05 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1092662/000000000020005032/0000000000-20-005032-index.htm |
2020-06-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1092662/000000000020005428/0000000000-20-005428-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000084608719000015/0000846087-19-000015-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000084608719000037/0000846087-19-000037-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000090221919000221/0000902219-19-000221-index.htm |
2020-01-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000090630420000009/0000906304-20-000009-index.htm |
2018-03-08 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/0001092662-18-000013-index.htm |
2018-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000109266218000020/0001092662-18-000020-index.htm |
2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000110465920021214/0001104659-20-021214-index.htm |
2020-03-20 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000110580620000018/0001105806-20-000018-index.htm |
2018-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118019625/0001140361-18-019625-index.htm |
2018-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118019921/0001140361-18-019921-index.htm |
2018-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036118022479/0001140361-18-022479-index.htm |
2018-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118022509/0001140361-18-022509-index.htm |
2018-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118024198/0001140361-18-024198-index.htm |
2018-05-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118024282/0001140361-18-024282-index.htm |
2018-05-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118024591/0001140361-18-024591-index.htm |
2018-05-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118025605/0001140361-18-025605-index.htm |
2018-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118026248/0001140361-18-026248-index.htm |
2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118028738/0001140361-18-028738-index.htm |
2018-07-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118032931/0001140361-18-032931-index.htm |
2018-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118034159/0001140361-18-034159-index.htm |
2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118035966/0001140361-18-035966-index.htm |
2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036118035995/0001140361-18-035995-index.htm |
2018-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118036236/0001140361-18-036236-index.htm |
2018-08-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118036265/0001140361-18-036265-index.htm |
2018-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118038547/0001140361-18-038547-index.htm |
2018-09-18 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118038659/0001140361-18-038659-index.htm |
2018-10-01 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1092662/000114036118039749/0001140361-18-039749-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040400/0001140361-18-040400-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040401/0001140361-18-040401-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040402/0001140361-18-040402-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040404/0001140361-18-040404-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040406/0001140361-18-040406-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040407/0001140361-18-040407-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040408/0001140361-18-040408-index.htm |
2018-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040410/0001140361-18-040410-index.htm |
2018-10-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040793/0001140361-18-040793-index.htm |
2018-10-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040795/0001140361-18-040795-index.htm |
2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040798/0001140361-18-040798-index.htm |
2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040799/0001140361-18-040799-index.htm |
2018-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118041036/0001140361-18-041036-index.htm |
2018-10-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036118041038/0001140361-18-041038-index.htm |
2018-10-31 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036118041895/0001140361-18-041895-index.htm |
2018-11-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036118042121/0001140361-18-042121-index.htm |
2018-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118042339/0001140361-18-042339-index.htm |
2018-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118042452/0001140361-18-042452-index.htm |
2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118042759/0001140361-18-042759-index.htm |
2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036118042769/0001140361-18-042769-index.htm |
2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118042903/0001140361-18-042903-index.htm |
2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036118043277/0001140361-18-043277-index.htm |
2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036118045466/0001140361-18-045466-index.htm |
2019-01-23 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119001391/0001140361-19-001391-index.htm |
2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119001543/0001140361-19-001543-index.htm |
2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119002877/0001140361-19-002877-index.htm |
2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119004442/0001140361-19-004442-index.htm |
2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119004572/0001140361-19-004572-index.htm |
2019-03-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1092662/000114036119005069/0001140361-19-005069-index.htm |
2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119005493/0001140361-19-005493-index.htm |
2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119006279/0001140361-19-006279-index.htm |
2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1092662/000114036119008079/0001140361-19-008079-index.htm |
2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119008168/0001140361-19-008168-index.htm |
2019-05-01 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/1092662/000114036119008194/0001140361-19-008194-index.htm |
2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036119008232/0001140361-19-008232-index.htm |
2019-05-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1092662/000114036119008668/0001140361-19-008668-index.htm |
2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036119008669/0001140361-19-008669-index.htm |
2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036119009826/0001140361-19-009826-index.htm |
2019-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119009935/0001140361-19-009935-index.htm |
2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119011520/0001140361-19-011520-index.htm |
2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036119011532/0001140361-19-011532-index.htm |
2019-07-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1092662/000114036119013107/0001140361-19-013107-index.htm |
2019-07-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119013144/0001140361-19-013144-index.htm |
2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119014341/0001140361-19-014341-index.htm |
2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036119014369/0001140361-19-014369-index.htm |
2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119014408/0001140361-19-014408-index.htm |
2019-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119016127/0001140361-19-016127-index.htm |
2019-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119016316/0001140361-19-016316-index.htm |
2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119020032/0001140361-19-020032-index.htm |
2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036119020057/0001140361-19-020057-index.htm |
2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036119020481/0001140361-19-020481-index.htm |
2019-11-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036119021382/0001140361-19-021382-index.htm |
2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120000583/0001140361-20-000583-index.htm |
2020-01-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120001160/0001140361-20-001160-index.htm |
2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120001172/0001140361-20-001172-index.htm |
2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120004604/0001140361-20-004604-index.htm |
2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120005684/0001140361-20-005684-index.htm |
2020-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1092662/000114036120005780/0001140361-20-005780-index.htm |
2020-03-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006258/0001140361-20-006258-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006259/0001140361-20-006259-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006260/0001140361-20-006260-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006261/0001140361-20-006261-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006262/0001140361-20-006262-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006263/0001140361-20-006263-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006264/0001140361-20-006264-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006265/0001140361-20-006265-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006266/0001140361-20-006266-index.htm |
2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120006397/0001140361-20-006397-index.htm |
2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120007757/0001140361-20-007757-index.htm |
2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120009307/0001140361-20-009307-index.htm |
2020-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1092662/000114036120010179/0001140361-20-010179-index.htm |
2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120010614/0001140361-20-010614-index.htm |
2020-05-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036120010632/0001140361-20-010632-index.htm |
2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120010633/0001140361-20-010633-index.htm |
2020-05-06 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1092662/000114036120010767/0001140361-20-010767-index.htm |
2020-05-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036120010828/0001140361-20-010828-index.htm |
2020-05-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036120011018/0001140361-20-011018-index.htm |
2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120011298/0001140361-20-011298-index.htm |
2020-05-11 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120011303/0001140361-20-011303-index.htm |
2020-05-29 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1092662/000114036120012751/0001140361-20-012751-index.htm |
2020-06-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1092662/000114036120013209/0001140361-20-013209-index.htm |
2020-06-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1092662/000114036120013971/0001140361-20-013971-index.htm |
2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120014016/0001140361-20-014016-index.htm |
2020-07-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120015539/0001140361-20-015539-index.htm |
2020-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120015570/0001140361-20-015570-index.htm |
2020-07-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1092662/000114036120015571/0001140361-20-015571-index.htm |
2020-07-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1092662/000114036120015575/0001140361-20-015575-index.htm |
2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120017393/0001140361-20-017393-index.htm |
2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120017671/0001140361-20-017671-index.htm |
2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036120017756/0001140361-20-017756-index.htm |
2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1092662/000114036120024677/0001140361-20-024677-index.htm |
2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1092662/000114036120024702/0001140361-20-024702-index.htm |
2018-03-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1092662/000114420418017263/0001144204-18-017263-index.htm |
2018-12-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000132531218000013/0001325312-18-000013-index.htm |
2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000132531219000002/0001325312-19-000002-index.htm |
2018-12-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1092662/000149315218017281/0001493152-18-017281-index.htm |
2018-10-03 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1092662/999999999518002536/9999999995-18-002536-index.htm |
Chembio Diagnostics, Inc (CEMI) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chembio Diagnostics, Inc (CEMI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1389%Institutional Ownership: 3375%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-05-24 | Javan Esfandiari | Officer | Sell | 9,744.00 | 6.95 | 67,726.65 | 108,773.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036119009826/0001140361-19-009826-index.htm |
2018-06-13 | Javan Esfandiari | Chief Science/Tech Officer | Buy | 20,000.00 | 5.64 | 112,800.00 | 111,258.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118028738/0001140361-18-028738-index.htm |
2019-05-06 | Katherine Lyon Davis | Director | Buy | 46,875.00 | 3.48 | 163,125.00 | 112,943.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036119008669/0001140361-19-008669-index.htm |
2019-05-23 | Javan Esfandiari | Officer | Sell | 12,956.00 | 7.15 | 92,582.28 | 118,517.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036119009826/0001140361-19-009826-index.htm |
2019-05-22 | Javan Esfandiari | Officer | Sell | 7,300.00 | 7.41 | 54,125.12 | 131,473.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036119009826/0001140361-19-009826-index.htm |
2018-10-08 | Javan Esfandiari | Officer | Buy | 38,860.00 | 138,773.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040407/0001140361-18-040407-index.htm | ||
2018-11-05 | Robert Passas | Officer | Buy | 15,000.00 | 6.75 | 101,250.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118042452/0001140361-18-042452-index.htm |
2018-10-08 | David Gyorke | Officer | Buy | 20,725.00 | 20,725.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040799/0001140361-18-040799-index.htm | ||
2018-05-16 | Sharon W Klugewicz | President, Americas | Buy | 5,000.00 | 4.50 | 22,500.00 | 21,448.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118024591/0001140361-18-024591-index.htm |
2018-11-14 | John Gary Potthoff | Director | Buy | 5,000.00 | 5.80 | 29,000.00 | 27,772.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118043277/0001140361-18-043277-index.htm |
2018-11-14 | John Gary Potthoff | Director | Buy | 15,000.00 | 5.81 | 87,150.00 | 27,772.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118043277/0001140361-18-043277-index.htm |
2019-11-11 | John Gary Potthoff | Director | Buy | 10,000.00 | 4.44 | 44,400.00 | 37,772.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036119020481/0001140361-19-020481-index.htm |
2020-01-17 | GAIL S PAGE | Officer | Buy | 30,864.00 | 38,636.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036120001172/0001140361-20-001172-index.htm | ||
2018-10-08 | Sharon W Klugewicz | Officer | Buy | 20,725.00 | 39,436.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040406/0001140361-18-040406-index.htm | ||
2018-10-08 | Neil A Goldman | Officer | Buy | 31,088.00 | 45,903.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040400/0001140361-18-040400-index.htm | ||
2019-06-18 | John J III Sperzel | Officer | Buy | 375,000.00 | 473,446.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036119011532/0001140361-19-011532-index.htm | ||
2018-10-08 | Katherine Lyon Davis | Director | Buy | 7,772.00 | 66,068.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040402/0001140361-18-040402-index.htm | ||
2018-10-08 | GAIL S PAGE | Director | Buy | 7,772.00 | 7,772.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040404/0001140361-18-040404-index.htm | ||
2018-10-08 | John Gary Potthoff | Director | Buy | 7,772.00 | 7,772.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040408/0001140361-18-040408-index.htm | ||
2018-10-08 | MARY LAKE PH D POLAN | Director | Buy | 7,772.00 | 7,772.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040410/0001140361-18-040410-index.htm | ||
2018-10-08 | John J III Sperzel | Officer | Buy | 98,446.00 | 98,446.00 | https://www.sec.gov/Archives/edgar/data/1092662/000114036118040401/0001140361-18-040401-index.htm |